Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Obstetricia y Ginecología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
Screening Breast Ultrasound in High-Risk Women
INTERVENTIONAL
Inicio: 1 de abr de 2004
ID: NCT00072501
Aún no recluta
ClinicalTrials.gov
Observational Pregnancy Safety Study of Women Exposed to Nifurtimox During Pregnancy to Describe the Risk of Pregnancy and Maternal Complications and Other Events of Interest on the Developing Fetus, Neonate, and Infant
OBSERVATIONAL
Inicio: 30 de jun de 2026
ID: NCT05477953
Activo, no recluta
ClinicalTrials.gov
A Randomised Phase III Trial of Adjuvant Radiation Therapy Versus Observation Following Breast Conserving Surgery and Endocrine Therapy in Patients With Molecularly Characterised Luminal A Early Breast Cancer
INTERVENTIONAL
Inicio: 21 de ago de 2017
ID: NCT02889874
Desconocido
Fase 2
ClinicalTrials.gov
A Multi-Center, Open-Label, Single-Arm Phase II Trial Assessing the Efficacy and Safety of Weekly Bolus Infusions of 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Advanced Breast Cancer Patients Who Failed Anthracycline and Taxane Chemotherapy Regimens
INTERVENTIONAL
Inicio: 1 de feb de 2006
ID: NCT00434369
Terminado
Fase 2
ClinicalTrials.gov
Open-label, Multi-cohort, Phase 2 Trial, Evaluating the Efficacy and Safety of Tusamitamab Ravtansine (SAR408701) Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors
INTERVENTIONAL
Inicio: 29 de mar de 2021
ID: NCT04659603
Completado
ClinicalTrials.gov
Development of a Non-invasive Diagnosis Tool for the Analysis of the Microbiota to Improve Reproductive Outcomes in Infertile Patients.
OBSERVATIONAL
Inicio: 4 de ago de 2017
ID: NCT03330444
Completado
ClinicalTrials.gov
A Prospective Epidemiological Study of Pregnancy Outcomes and of Events of Interest in Pregnant Women, Neonates and Infants (PEPNI)
INTERVENTIONAL
Inicio: 30 de may de 2019
ID: NCT03614676
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (TroFuse-020/GOG-3101/ENGOT-cx20)
INTERVENTIONAL
Inicio: 24 de jul de 2024
ID: NCT06459180
Reclutando
ClinicalTrials.gov
Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS). A Multicenter Randomized Phase III Trial (OPBC-03/ SAKK 23/16 /IBCSG 57-18 / ABCSG-53 / GBG-101)
INTERVENTIONAL
Inicio: 7 de ago de 2018
ID: NCT03513614
Completado
Fase 3
ClinicalTrials.gov
SPIRIT EXTENSION: An International Phase 3 Open-Label, Single-Arm, Safety and Efficacy Extension Study to Evaluate Relugolix Co-Administered With Low-Dose Estradiol and Norethindrone Acetate in Women With Endometriosis-Associated Pain
INTERVENTIONAL
Inicio: 22 de may de 2018
ID: NCT03654274
Completado
Fase 3
ClinicalTrials.gov
SPIRIT 1: An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Administered With and Without Low-Dose Estradiol and Norethindrone Acetate in Women With Endometriosis-Associated Pain
INTERVENTIONAL
Inicio: 7 de dic de 2017
ID: NCT03204318
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
INTERVENTIONAL
Inicio: 12 de jul de 2017
ID: NCT03155997
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Phase II, Multicenter, Randomized, Double-Blind Study of Tobemstomig/RO7247669 Combined With Nab-Paclitaxel Compared With Pembrolizumab Combined With Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer
INTERVENTIONAL
Inicio: 18 de jul de 2023
ID: NCT05852691
Reclutando
ClinicalTrials.gov
Advanced Wireless Sensors for Neonatal Care in the Delivery Room: the AWARD Prospective Multicenter International Study
INTERVENTIONAL
Inicio: 8 de abr de 2025
ID: NCT06693817
Completado
Fase 3
ClinicalTrials.gov
A Phase III Randomized, Double-blind, Placebo-controlled Study of LEE011 or Placebo in Combination With Tamoxifen and Goserelin or a Non-steroidal Aromatase Inhibitor (NSAI) and Goserelin for the Treatment of Premenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
INTERVENTIONAL
Inicio: 20 de nov de 2014
ID: NCT02278120
Completado
Fase 3
ClinicalTrials.gov
A Phase III Trial to Compare the Safety and Efficacy of Lapatinib Plus Trastuzumab Plus an Aromatase Inhibitor (AI) vs. Trastuzumab Plus an AI vs. Lapatinib Plus an AI as 1st- or 2nd- Line Therapy in Postmenopausal Subjects With Hormone Receptor+, HER2-positive Metastatic Breast Cancer (MBC) Who Received Prior Trastuzumab and Endocrine Therapies
INTERVENTIONAL
Inicio: 5 de may de 2011
ID: NCT01160211
Completado
Fase 3
ClinicalTrials.gov
A Multicenter Randomized Phase III Study to Compare the Combination Trastuzumab and Capecitabine, With or Without Pertuzumab, in Patients With HER2-Positive Metastatic Breast Cancer That Have Progressed After One Line of Trastuzumab-Based Therapy in the Metastatic Setting (PHEREXA)
INTERVENTIONAL
Inicio: 26 de ene de 2010
ID: NCT01026142
Completado
Fase 1
ClinicalTrials.gov
A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion (ANX-530) in Patients With Advanced Cancer.
INTERVENTIONAL
Inicio: 1 de feb de 2007
ID: NCT00432562
Reclutando
Fase 3
ClinicalTrials.gov
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4 Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (Bluestar-Endometrial01)
INTERVENTIONAL
Inicio: 1 de ago de 2025
ID: NCT07044336
Terminado
Fase 3
ClinicalTrials.gov
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
INTERVENTIONAL
Inicio: 15 de dic de 2015
ID: NCT02853604
Anterior
1
...
6
7
8
...
434
Siguiente
Filtros